These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 21647204)

  • 1. Pathogenesis of systemic juvenile idiopathic arthritis: some answers, more questions.
    Mellins ED; Macaubas C; Grom AA
    Nat Rev Rheumatol; 2011 Jun; 7(7):416-26. PubMed ID: 21647204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural Killer Cells in Systemic Autoinflammatory Diseases: A Focus on Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome.
    Vandenhaute J; Wouters CH; Matthys P
    Front Immunol; 2019; 10():3089. PubMed ID: 32010140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophils From Children With Systemic Juvenile Idiopathic Arthritis Exhibit Persistent Proinflammatory Activation Despite Long-Standing Clinically Inactive Disease.
    Brown RA; Henderlight M; Do T; Yasin S; Grom AA; DeLay M; Thornton S; Schulert GS
    Front Immunol; 2018; 9():2995. PubMed ID: 30619348
    [No Abstract]   [Full Text] [Related]  

  • 4. Cytokines in systemic juvenile idiopathic arthritis and haemophagocytic lymphohistiocytosis: tipping the balance between interleukin-18 and interferon-γ.
    Put K; Avau A; Brisse E; Mitera T; Put S; Proost P; Bader-Meunier B; Westhovens R; Van den Eynde BJ; Orabona C; Fallarino F; De Somer L; Tousseyn T; Quartier P; Wouters C; Matthys P
    Rheumatology (Oxford); 2015 Aug; 54(8):1507-17. PubMed ID: 25767156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IDO1 Deficiency Does Not Affect Disease in Mouse Models of Systemic Juvenile Idiopathic Arthritis and Secondary Hemophagocytic Lymphohistiocytosis.
    Put K; Brisse E; Avau A; Imbrechts M; Mitera T; Janssens R; Proost P; Fallarino F; Wouters CH; Matthys P
    PLoS One; 2016; 11(2):e0150075. PubMed ID: 26914138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse models of systemic juvenile idiopathic arthritis and macrophage activation syndrome.
    Inoue N; Schulert GS
    Arthritis Res Ther; 2023 Mar; 25(1):48. PubMed ID: 36964620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An unusual presentation of purine nucleoside phosphorylase deficiency mimicking systemic juvenile idiopathic arthritis complicated by macrophage activation syndrome.
    Arduini A; Marasco E; Marucci G; Pardeo M; Insalaco A; Caiello I; Moneta GM; Prencipe G; De Benedetti F; Bracaglia C
    Pediatr Rheumatol Online J; 2019 May; 17(1):25. PubMed ID: 31118063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine balance and cytokine-driven natural killer cell dysfunction in systemic juvenile idiopathic arthritis.
    Avau A; Put K; Wouters CH; Matthys P
    Cytokine Growth Factor Rev; 2015 Feb; 26(1):35-45. PubMed ID: 24948570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternative activation in systemic juvenile idiopathic arthritis monocytes.
    Macaubas C; Nguyen KD; Peck A; Buckingham J; Deshpande C; Wong E; Alexander HC; Chang SY; Begovich A; Sun Y; Park JL; Pan KH; Lin R; Lih CJ; Augustine EM; Phillips C; Hadjinicolaou AV; Lee T; Mellins ED
    Clin Immunol; 2012 Mar; 142(3):362-72. PubMed ID: 22281427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic juvenile idiopathic arthritis: New insights into pathogenesis and cytokine directed therapies.
    Pardeo M; Bracaglia C; De Benedetti F
    Best Pract Res Clin Rheumatol; 2017 Aug; 31(4):505-516. PubMed ID: 29773270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complications of systemic juvenile idiopathic arthritis: risk factors and management recommendations.
    Woerner A; von Scheven-Gête A; Cimaz R; Hofer M
    Expert Rev Clin Immunol; 2015 May; 11(5):575-88. PubMed ID: 25843554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current understanding of the pathophysiology of systemic juvenile idiopathic arthritis (sJIA) and target-directed therapeutic approaches.
    Bruck N; Schnabel A; Hedrich CM
    Clin Immunol; 2015 Jul; 159(1):72-83. PubMed ID: 25956529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis.
    Behrens EM; Beukelman T; Paessler M; Cron RQ
    J Rheumatol; 2007 May; 34(5):1133-8. PubMed ID: 17343315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on the pathogenesis and treatment of systemic idiopathic arthritis.
    Sikora KA; Grom AA
    Curr Opin Pediatr; 2011 Dec; 23(6):640-6. PubMed ID: 22045308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetics of Macrophage Activation Syndrome in Systemic Juvenile Idiopathic Arthritis.
    Grom AA
    Adv Exp Med Biol; 2024; 1448():121-126. PubMed ID: 39117811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiating macrophage activation syndrome in systemic juvenile idiopathic arthritis from other forms of hemophagocytic lymphohistiocytosis.
    Lehmberg K; Pink I; Eulenburg C; Beutel K; Maul-Pavicic A; Janka G
    J Pediatr; 2013 Jun; 162(6):1245-51. PubMed ID: 23333131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monocyte and bone marrow macrophage transcriptional phenotypes in systemic juvenile idiopathic arthritis reveal TRIM8 as a mediator of IFN-γ hyper-responsiveness and risk for macrophage activation syndrome.
    Schulert GS; Pickering AV; Do T; Dhakal S; Fall N; Schnell D; Medvedovic M; Salomonis N; Thornton S; Grom AA
    Ann Rheum Dis; 2021 May; 80(5):617-625. PubMed ID: 33277241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage activation syndrome and cytokine-directed therapies.
    Schulert GS; Grom AA
    Best Pract Res Clin Rheumatol; 2014 Apr; 28(2):277-92. PubMed ID: 24974063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-18 as a biomarker linking systemic juvenile idiopathic arthritis and macrophage activation syndrome.
    Yasin S; Fall N; Brown RA; Henderlight M; Canna SW; Girard-Guyonvarc'h C; Gabay C; Grom AA; Schulert GS
    Rheumatology (Oxford); 2020 Feb; 59(2):361-366. PubMed ID: 31326996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic JIA: new developments in the understanding of the pathophysiology and therapy.
    Vastert SJ; Kuis W; Grom AA
    Best Pract Res Clin Rheumatol; 2009 Oct; 23(5):655-64. PubMed ID: 19853830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.